Women`s Health and Phlebology: Clinical and Pharmacological Principles and Practices

Women`s Health and Phlebology: Clinical and Pharmacological Principles and Practices is a Bahamas cruise conference round-trip from Cape Liberty (Bayonne), NJ.

Topics

• Drug interactions; a primer and refresher for all areas of clinical practice
• Pharmacokinetic and pharmacodynamic challenges to manage women`s health
• Clinical pearls to improve safe medication use in special populations
• Navigating behavioral and psychological symptoms of dementia and neurocognitive disorders commonly seen in our aging female patients
• Identifying and navigating the caveats and challenges when treating female patients diagnosed with mental illness (including the new mixed feature diagnosis associated with major depression)
• Addressing the challenges of treating postpartum depression
• Topics:
• Exploring opportunities to decrease the risk of metabolic syndrome; current recommendations to address this increasingly more common medical condition
• Pharmacokinetic and pharmacodynamic challenges to manage women`s health including a review of drug interactions; a primer and refresher for all areas of clinical practice
• Addressing pharmacological consequences of aging
• Identify he challenges of applying FDA black box warnings and other age specific recommendations in this population
• Describe physiologic changes that are associated with aging that can alter the intended effects of medication and may increase risk of unintended consequences of using medications in the older adult
• Addressing pharmacological consequences of aging
• Apply clinical pearls to improve medication medication safety in this population
• Describe the impact of untreated BPSD on patients and caregivers
• Navigating behavioral and psychological symptoms of dementia and neurocognitive disorders commonly seen in our aging female patients
• Apply clinical pearls to improve medication medication safety in this population
• Identify the current treatment options and opportunities to avoid pitfalls when initiating drug therapy in these patients
• Addressing the challenges of treating postpartum depression
• Clinical pearls to improve safe medication use in special populations
• Describe the challenges of applying the new FDA pregnancy warnings to medication therapy in women of childbearing age
• Identify medications available for the treatment of postpartum depression including the newest parenteral agent approved in 2019
• Clinical pearls to improve safe medication use in special populations
• Apply clinical pearls to improve medication adherence in this population
• Identify the current medications available for treating female patients with common mental health conditions
• Identifying and addressing the caveats and challenges associated with treatment in female patients diagnosed with mental illness (including the new mixed feature diagnosis associated with major depression)
• Apply clinical pearls for safe and effective medication use in patients with co-occuring medical and psychiatric conditions
• Describe the challenges, risks and benefits in using various pharmacotherapeutic interventions in this population
• Navigating metabolic syndrome; current recommendations to address this increasingly more common medical complication
• Clinical pearls to improve safe medication use in special populations
• Describe the differences in guidelines and how to engage the patient in the debate of negotiated clinical outcomes
• Identify the new medications available for diabetes, hyperlipidemia and hypertension and review current guidelines recommending appropriate use
• Apply clinical pearls for use of medication therapy in women

Who should Attend

• Physician Assistants
• Physicians
• Nurse Practitioners
• Nurses
• Pharmacists